Rotator Cuff Tear. Complete rotator cuff tear or rupture not specified as traumatic
Conditions
Interventions
Intervention 1: Intervention group: Participants in the intervention group will receive an oral vitamin C supplement at a daily dose of 500 mg, starting from the first day after surgery and continuing
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over the age of 18 undergoing open surgical repair for rotator cuff tears Confirmation of full-thickness tear in one or more rotator cuff tendons based on preoperative MRI assessment and intraoperative verification. "Provision of written informed consent to participate in the study and commitment to postoperative follow-up according to the specified schedule Adequate general health status to undergo the standard postoperative treatment and rehabilitation process
Exclusion criteria
Exclusion criteria: Shoulder Revision Surgery "Presence of neurological or muscular disorders that may affect shoulder functional outcomes (e.g., neuromuscular diseases) Presence of significant concomitant injuries to other shoulder structures (e.g., extensive glenoid labrum tear or advanced glenohumeral joint osteoarthritis) "Pregnancy or the presence of uncontrolled systemic diseases such as uncontrolled diabetes mellitus or advanced renal failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of the mean (± standard deviation) scores of upper limb function (QuickDASH) in the ascorbic acid intervention group and the control group. Timepoint: Week 12 and Week 24. Method of measurement: QuickDASH Questionnaire.;Comparison of mean upper limb functional scores (QuickDASH) between the ascorbic acid intervention group and the control group. Timepoint: Week 12 and Week 24 after surgery. Method of measurement: QuickDASH Questionnaire.;Etermination of the mean (± standard deviation) pain intensity scores in the ascorbic acid intervention group and the control group. Timepoint: At weeks 2, 6, 12, and 24 following the surgery. Method of measurement: Visual Analogue Scale Questionnaire.;Comparison of the Mean Pain Intensity Between the Ascorbic Acid Group and the Control Group. Timepoint: At weeks 2, 6, 12, and 24 following the surgery. Method of measurement: Visual Analogue Scale Questionnaire.;Determination of the Mean (Standard Deviation) of Shoulder Joint Range of Motion (ROM) in the Ascorbic Acid Group and the Control Group. Timepoint: Weeks 12 and 24 following the surgery. Method of measurement: Using an instrument called a goniometer.;Comparison of the Mean Shoulder Joint Range of Motion (ROM) Between the Ascorbic Acid Group and the Control Group. Timepoint: Weeks 12 and 24 following the surgery. Method of measurement: Using an instrument called a goniometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Ebadi
Iran University of Medical Sciences
Outcome results
None listed